Home » All » Stock Forecast » Bicara Therapeutics Inc. Common Stock Forecast

Bicara Therapeutics Inc. Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▼ -1.53%Market Cap $1.51B · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$22.91 ▼ -0.88%	Yesterday	$23.20 ▲ +0.37%	Tomorrow's Bicara Therapeutics Inc. Common Stock (BCAX) setup is anchored to $23.11 and targets $22.91 (-0.88%). The near-term read is downside; watch $23.80 / $22.42 because daily realized volatility is about 4.56%.
Tomorrow's Bicara Therapeutics Inc. Common Stock (BCAX) setup is anchored to $23.11 and targets $22.91 (-0.88%). The near-term read is downside; watch $23.80 / $22.42 because daily realized volatility is about 4.56%.
Week	$22.47 ▼ -2.75%	Last Week	$23.38 ▲ +1.16%	The 7-day Bicara Therapeutics Inc. Common Stock model moves from $23.38 to $22.47 (-2.75%). It gives downside momentum context for this stock, so breaks around $23.80 / $22.42 matter more than a single tick.
The 7-day Bicara Therapeutics Inc. Common Stock model moves from $23.38 to $22.47 (-2.75%). It gives downside momentum context for this stock, so breaks around $23.80 / $22.42 matter more than a single tick.
Month	$21.76 ▼ -5.86%	Last Month	$23.68 ▲ +2.46%	The 1-month Bicara Therapeutics Inc. Common Stock target is $21.76 (-5.86%), compared with the live reference near $23.11. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Bicara Therapeutics Inc. Common Stock target is $21.76 (-5.86%), compared with the live reference near $23.11. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$20.68 ▼ -10.51%	Last Year	$24.13 ▲ +4.42%	The 1-year Bicara Therapeutics Inc. Common Stock scenario points to $20.68 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Bicara Therapeutics Inc. Common Stock scenario points to $20.68 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$18.16 ▼ -21.43%	5 Years Ago	$25.19 ▲ +9.00%	The 5-year Bicara Therapeutics Inc. Common Stock view is $18.16 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Bicara Therapeutics Inc. Common Stock view is $18.16 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$22.91▼ -0.88%

Yesterday$23.20▲ +0.37%

Tomorrow's Bicara Therapeutics Inc. Common Stock (BCAX) setup is anchored to $23.11 and targets $22.91 (-0.88%). The near-term read is downside; watch $23.80 / $22.42 because daily realized volatility is about 4.56%.

Week$22.47▼ -2.75%

Last Week$23.38▲ +1.16%

The 7-day Bicara Therapeutics Inc. Common Stock model moves from $23.38 to $22.47 (-2.75%). It gives downside momentum context for this stock, so breaks around $23.80 / $22.42 matter more than a single tick.

Month$21.76▼ -5.86%

Last Month$23.68▲ +2.46%

The 1-month Bicara Therapeutics Inc. Common Stock target is $21.76 (-5.86%), compared with the live reference near $23.11. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$20.68▼ -10.51%

Last Year$24.13▲ +4.42%

The 1-year Bicara Therapeutics Inc. Common Stock scenario points to $20.68 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$18.16▼ -21.43%

5 Years Ago$25.19▲ +9.00%

The 5-year Bicara Therapeutics Inc. Common Stock view is $18.16 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Bearish

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$23.11	Mid
Daily Change	-1.53%	Below
Volatility Cap	20.0%	Mid
Confidence	60%	Below
Data Source	nasdaq-screener	Mid

Historical Data

Current$23.11

Daily Change-1.53%

Market Cap$1.51B

Sourcenasdaq-screener

Current	$23.11	Daily Change	-1.53%
Market Cap	$1.51B	Source	nasdaq-screener

Support & Resistance Levels

$22.42Support 1

$23.11Current

$23.80Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$23.11Live reference price

Used as the anchor for generated forecast calculations.

Next Month$21.76Model projection-5.86%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

60%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

60%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in BCAX today

Bullish Scenario

$24.27

+5.00% from current

Target Price$24.27

ScenarioUpside momentum

Probability52%

Base Scenario

$21.76

-5.86%

Target Price$21.76

ScenarioCapped drift

Probability60%

Bearish Scenario

$21.95

-5.00% from current

Target Price$21.95

ScenarioVolatility drawdown

Probability40%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bearish · 38/100

24H drift-0.88%

7D drift-2.75%

30D drift-5.86%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-Off Caution · 31/100

1M outlook-5.86%

1Y outlook-10.51%

5Y outlook-21.43%

Frequently Asked Questions

Q What is the Bicara Therapeutics Inc. Common Stock (BCAX) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Bicara Therapeutics Inc. Common Stock is projected near $22.91 versus the current reference around $23.11. That implies a modeled move of -0.88% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for BCAX?

The weekly Bicara Therapeutics Inc. Common Stock model points to $22.47, which maps to an expected drift of -2.75% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Bicara Therapeutics Inc. Common Stock 1-month and 1-year targets?

The Bicara Therapeutics Inc. Common Stock 1-month target is $21.76 (-5.86%), while the 1-year target is $20.68 (-10.51%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Bicara Therapeutics Inc. Common Stock 5-year scenario differ from short-term rows?

The Bicara Therapeutics Inc. Common Stock long-horizon scenario sits near $18.16 with a modeled change of -21.43%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are BCAX support and resistance zones right now?

For Bicara Therapeutics Inc. Common Stock, nearest resistance is around $22.42, while nearest support is around $23.80. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Bicara Therapeutics Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.